HIV in prison in low-income and middle-income countries

被引:175
|
作者
Dolan, Kate [1 ]
Kite, Ben
Black, Emma
Aceijas, Carmen
Stimson, Gerry V.
机构
[1] Univ New S Wales, Program Int Res & Training, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia
[2] Univ London Imperial Coll Sci Technol & Med, Ctr Res Drugs & Hlth Behav, Dept Primary Care & Social Med, London, England
[3] Int Harm Reduct Assoc, Melbourne, Vic, Australia
来源
LANCET INFECTIOUS DISEASES | 2007年 / 7卷 / 01期
关键词
D O I
10.1016/S1473-3099(06)70685-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
High prevalence of HIV infection and the over-representation of injecting drug users (IDUs) in prisons combined with HIV risk behaviour create a crucial public-health issue for correctional institutions and, at a broader level, the communities in which they are situated. However, data relevant to this problem are limited and difficult to access. We reviewed imprisonment, HIV prevalence, and the proportion of prisoners who are IDUs in 152 low-income and middle-income countries. Information on imprisonment was obtained for 142 countries. Imprisonment rates ranged from 23 per 100000 population in Burkina Faso to 532 per 100000 in Belarus and Russia. Information on HIV prevalence in prisons was found for 75 countries. Prevalence was greater than 10% in prisons in 20 countries. Eight countries reported prevalence of IDUs in prison of greater than 10%. HIV prevalence among IDU prisoners was reported in eight countries and was greater than 10% in seven of those. Evidence of HIV transmission in prison was found for seven low-income and middle-income countries. HIV is a serious problem for many countries, especially where injection drug use occurs. Because of the paucity of data available, the contribution of HIV within prison settings is difficult to determine in many low-income and middle-income countries. Systematic collection of data to inform HIV prevention strategies in prison is urgently needed. The introduction and evaluation of HIV prevention strategies in prisons are warranted.
引用
收藏
页码:32 / 41
页数:10
相关论文
共 50 条
  • [1] Financing the Response to HIV in Low-Income and Middle-Income Countries
    Izazola-Licea, Jose Antonio
    Wiegelmann, Jan
    Aran, Christian
    Guthrie, Teresa
    De Lay, Paul
    Avila-Figueroa, Carlos
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 : S119 - S126
  • [2] HIV drug resistance in low-income and middle-income countries
    Hamers, Raph L.
    de Wit, Tobias F. Rinke
    Holmes, Charles B.
    [J]. LANCET HIV, 2018, 5 (10): : E588 - E596
  • [3] Smoking status and HIV in low-income and middle-income countries
    Jaquet, Antoine
    Dabis, Francois
    [J]. LANCET GLOBAL HEALTH, 2017, 5 (06): : E557 - E558
  • [4] Brucellosis in low-income and middle-income countries
    Rubach, Matthew P.
    Halliday, Jo E. B.
    Cleaveland, Sarah
    Crump, John A.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2013, 26 (05) : 404 - 412
  • [5] Anaemia in low-income and middle-income countries
    Balarajan, Yarlini
    Ramakrishnan, Usha
    Oezaltin, Emre
    Shankar, Anuraj H.
    Subramanian, S. V.
    [J]. LANCET, 2011, 378 (9809): : 2123 - 2135
  • [6] Integrated surveillance of HIV care in low-income and middle-income countries
    Tassie, Jean-Michel
    Bertagnolio, Silvia
    Souteyrand, Yves
    [J]. CURRENT OPINION IN HIV AND AIDS, 2011, 6 (04) : 233 - 238
  • [7] Antibiotic consumption in low-income and middle-income countries
    Hamers, Raph L.
    van Doorn, H. Rogier
    [J]. LANCET GLOBAL HEALTH, 2018, 6 (07): : E732 - E732
  • [8] Surgical services in low-income and middle-income countries
    Spiegel, David A.
    Gosselin, Richard A.
    [J]. LANCET, 2007, 370 (9592): : 1013 - 1015
  • [9] Tobacco killing in low-income and middle-income countries
    不详
    [J]. LANCET, 2012, 379 (9822): : 1172 - 1172
  • [10] Alcohol burden in low-income and middle-income countries
    Connor, Jason P.
    Hall, Wayne
    [J]. LANCET, 2015, 386 (10007): : 1922 - 1924